Britain's health regulator has approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years.
The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got regulatory nod for use in children aged 12 to 15.
Moderna's vaccine was recommended for use in adolescents by European regulators in July and is awaiting US authorisation.
It is currently approved for people over the age of 18 in the UK.
Britain's Joint Committee on Vaccination and Immunisation (JCVI) gave the go-ahead on August 4 for 16 and 17-year-olds to get their first dose of Pfizer's COVID-19 vaccine ahead of schools returning in September.
JCVI will make a decision on whether the vaccine will be deployed or not.


France boosts police presence, hoping to prevent repeat of riots
Russia, Ukraine agree to Oleshky ceasefire brokered by Melania Trump
Seven killed in attack at church funeral in Jordan
Gunman fires from car near Paris, killing 1
Injuries in Tibet rises to 76 after earthquake, death toll remains at 16
